Cart summary

You have no items in your shopping cart.

PPARγ agonist 6

SKU: orb1687462

Description

PPARγ agonist 6

Images & Validation

Key Properties

CAS Number2428742-08-7
MW442.51
FormulaC27H26N2O4
SMILESC(N1C=2C(=C(C(OC)=O)C=CC2)N=C1CCC)C3=CC=C(C=C3)C4=C(C(OC)=O)C=CC=C4
TargetPPAR,Others

Storage & Handling

Storage-20°C
DisclaimerFor research use only

Similar Products

  • (±)19(20)-EDP Ethanolamide [orb1985154]

    2123485-34-5

    387.564

    C24H37NO3

    50 μg, 25 μg, 100 μg, 500 μg
  • PPARγ agonist 5 [orb1686479]

    915124-86-6

    513.63

    C33H31N5O

    25 mg, 100 mg, 50 mg
  • PPARγ agonist 7 [orb1688619]

    2569295-93-6

    366.45

    C20H30O6

    25 mg, 100 mg, 50 mg
  • Leriglitazone hydrochloride [orb1983413]

    146062-46-6

    408.90

    C19H21ClN2O4S

    50 mg, 5 mg
  • MTX-531 [orb2564258]

    2791417-66-6

    453.94

    C22H20ClN5O2S

    25 mg, 100 mg, 50 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

PPARγ agonist 6 (orb1687462)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%